Works matching American Association for Cancer Research (AACR)


Results: 84
    1
    2
    3
    4
    5
    6
    7
    8
    9

    The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomasPresented in part at the American Society of Clinical Oncology—Gastrointestinal (ASCO‐GI) Symposium, January 26–28, 2006, San Francisco, California; and at the Annual Meeting of the American Association for Cancer Research (AACR), April 1–5, 2006, Washington, D.C.

    Published in:
    Cancer (0008543X), 2006, v. 106, n. 10, p. 2119, doi. 10.1002/cncr.21850
    By:
    • Björn L. D. M. Brücher;
    • Karen Becker;
    • Florian Lordick;
    • Ulrich Fink;
    • Mario Sarbia;
    • Hubert Stein;
    • Raymonde Busch;
    • Frank Zimmermann;
    • Michael Molls;
    • Heinz Höfler;
    • Jörg R. Siewert
    Publication type:
    Article
    10
    11
    12
    13
    14

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology Practice, 2024, v. 11, n. 1, p. 108, doi. 10.1093/nop/npad084
    Publication type:
    Article
    15

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology Practice, 2023, v. 10, n. 6, p. 599, doi. 10.1093/nop/npad069
    Publication type:
    Article
    16

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology Practice, 2023, v. 10, n. 5, p. 495, doi. 10.1093/nop/npad052
    By:
    • Taylor, Jennie W
    Publication type:
    Article
    17

    Society News.

    Published in:
    Neuro-Oncology Practice, 2023, v. 10, n. 2, p. 214, doi. 10.1093/nop/npad011
    Publication type:
    Article
    18

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology Practice, 2023, v. 10, n. 1, p. 108, doi. 10.1093/nop/npac096
    Publication type:
    Article
    19

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology Practice, 2022, v. 9, n. 6, p. 562, doi. 10.1093/nop/npac080
    Publication type:
    Article
    20

    Society News.

    Published in:
    Neuro-Oncology Practice, 2022, v. 9, n. 5, p. 458, doi. 10.1093/nop/npac066
    Publication type:
    Article
    21
    22
    23

    Primary Analysis of Phase 2 Results for Cemiplimab in Patients with mBCC Who Progressed on or Were Intolerant to Hedgehog Inhibitors.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 11, p. 387
    By:
    • Lewis, Karl D.;
    • Peris, Ketty;
    • Sekulic, Aleksandar;
    • Stratigos, Alexander J.;
    • Dunn, Lara;
    • Eroglu, Zeynep;
    • Chang, Anne Lynn S.;
    • Migden, Michael R.;
    • Suk-Young Yoo;
    • Mohan, Kosalai;
    • Coates, Ebony;
    • Okoye, Emmanuel;
    • Baurain, Jean-François;
    • Bechter, Oliver;
    • Hauschild, Axel;
    • Butler, Marcus O.;
    • Hernandez-Aya, Leonel;
    • Licitra, Lisa;
    • Neves, Rogerio I.;
    • Ruiz, Emily S.
    Publication type:
    Article
    24

    New dream team for melanoma therapy.

    Published in:
    Pigment Cell & Melanoma Research, 2012, v. 25, n. 2, p. 279, doi. 10.1111/j.1755-148X.2012.00968.x
    By:
    • Herlyn, Meenhard
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    37
    38
    39
    40

    Cancer research award.

    Published in:
    JAMA: Journal of the American Medical Association, 1995, v. 274, n. 21, p. 1740f
    Publication type:
    Article
    41

    Cancer research award.

    Published in:
    JAMA: Journal of the American Medical Association, 1995, v. 274, n. 16, p. 1322d
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50